All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?
…plans. A growing number of European regulatory authorities have been using novel managed entry agreements (MEA) and innovative access agreements (IAA) to accelerate approval times and improve availability to patients….
Innovative Access Arrangements and Managed Entry
A growing number of payers in many countries are looking to managed entry agreements (MEAs) and other innovative access arrangements (IAAs) to allow rapid access to medicines that address significant…
Increasing Access to Innovative Medicines
…the onset, they worked toward agreements with nations and competitors to increase manufacturing capacity and minimize pharmaceutical supply chain disruption. IMC members demonstrated the industry’s value to the world, as…
Innovative Agreements Framework
…describes innovative agreements being used in jurisdictions outside Canada. We prepared it to guide discussions with the pCPA Governing Council on the merits of jointly developing an innovative agreements framework….
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…
